These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18470638)

  • 1. Chromatography-based purification of adeno-associated virus.
    Smith RH; Yang L; Kotin RM
    Methods Mol Biol; 2008; 434():37-54. PubMed ID: 18470638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of recombinant adeno-associated virus vectors by column chromatography and its performance in vivo.
    Gao G; Qu G; Burnham MS; Huang J; Chirmule N; Joshi B; Yu QC; Marsh JA; Conceicao CM; Wilson JM
    Hum Gene Ther; 2000 Oct; 11(15):2079-91. PubMed ID: 11044910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum-free production and column purification of adeno-associated virus type 5.
    Smith RH; Ding C; Kotin RM
    J Virol Methods; 2003 Dec; 114(2):115-24. PubMed ID: 14625046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography.
    Kaludov N; Handelman B; Chiorini JA
    Hum Gene Ther; 2002 Jul; 13(10):1235-43. PubMed ID: 12133276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications.
    Burova E; Ioffe E
    Gene Ther; 2005 Oct; 12 Suppl 1():S5-17. PubMed ID: 16231055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Analysis of Cesium Chloride- and Iodixanol-Based Purification of Recombinant Adeno-Associated Viral Vectors for Preclinical Applications.
    Strobel B; Miller FD; Rist W; Lamla T
    Hum Gene Ther Methods; 2015 Aug; 26(4):147-57. PubMed ID: 26222983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and purification of recombinant adeno-associated vectors.
    Wang L; Blouin V; Brument N; Bello-Roufai M; Francois A
    Methods Mol Biol; 2011; 807():361-404. PubMed ID: 22034039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation of adeno-associated virus type 2 empty particles from genome containing vectors by anion-exchange column chromatography.
    Qu G; Bahr-Davidson J; Prado J; Tai A; Cataniag F; McDonnell J; Zhou J; Hauck B; Luna J; Sommer JM; Smith P; Zhou S; Colosi P; High KA; Pierce GF; Wright JF
    J Virol Methods; 2007 Mar; 140(1-2):183-92. PubMed ID: 17196264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scaleable chromatographic purification process for recombinant adeno-associated virus (rAAV).
    O'Riordan CR; Lachapelle AL; Vincent KA; Wadsworth SC
    J Gene Med; 2000; 2(6):444-54. PubMed ID: 11199265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scalable method utilizing low pH for DNA removal in the harvest of recombinant adeno-associated virus vectors.
    Heldt CL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Aug; 1124():173-179. PubMed ID: 31203107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of recombinant adeno-associated virus type 8 vectors by ion exchange chromatography generates clinical grade vector stock.
    Davidoff AM; Ng CY; Sleep S; Gray J; Azam S; Zhao Y; McIntosh JH; Karimipoor M; Nathwani AC
    J Virol Methods; 2004 Nov; 121(2):209-15. PubMed ID: 15381358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector.
    Grieger JC; Soltys SM; Samulski RJ
    Mol Ther; 2016 Feb; 24(2):287-297. PubMed ID: 26437810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scalable purification of adeno-associated virus serotype 1 (AAV1) and AAV8 vectors, using dual ion-exchange adsorptive membranes.
    Okada T; Nonaka-Sarukawa M; Uchibori R; Kinoshita K; Hayashita-Kinoh H; Nitahara-Kasahara Y; Takeda S; Ozawa K
    Hum Gene Ther; 2009 Sep; 20(9):1013-21. PubMed ID: 19534598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adeno-associated virus serotypes: vector toolkit for human gene therapy.
    Wu Z; Asokan A; Samulski RJ
    Mol Ther; 2006 Sep; 14(3):316-27. PubMed ID: 16824801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical Ultracentrifugation as an Approach to Characterize Recombinant Adeno-Associated Viral Vectors.
    Burnham B; Nass S; Kong E; Mattingly M; Woodcock D; Song A; Wadsworth S; Cheng SH; Scaria A; O'Riordan CR
    Hum Gene Ther Methods; 2015 Dec; 26(6):228-42. PubMed ID: 26414997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scalable Production and Purification of Adeno-Associated Viral Vectors (AAV).
    Blessing D; Déglon N; Schneider BL
    Methods Mol Biol; 2018; 1850():259-274. PubMed ID: 30242692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AAV-Mediated Gene Delivery to the Lung.
    van Lieshout LP; Domm JM; Wootton SK
    Methods Mol Biol; 2019; 1950():361-372. PubMed ID: 30783985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A versatile and scalable two-step ion-exchange chromatography process for the purification of recombinant adeno-associated virus serotypes-2 and -5.
    Brument N; Morenweiser R; Blouin V; Toublanc E; Raimbaud I; Chérel Y; Folliot S; Gaden F; Boulanger P; Kroner-Lux G; Moullier P; Rolling F; Salvetti A
    Mol Ther; 2002 Nov; 6(5):678-86. PubMed ID: 12436964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adeno-associated viruses.
    Mezzina M; Merten OW
    Methods Mol Biol; 2011; 737():211-34. PubMed ID: 21590399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotype-independent method of recombinant adeno-associated virus (AAV) vector production and purification.
    Miyake K; Miyake N; Yamazaki Y; Shimada T; Hirai Y
    J Nippon Med Sch; 2012; 79(6):394-402. PubMed ID: 23291836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.